Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · IEX Real-Time Price · USD
1.100
0.00 (0.00%)
At close: Jul 2, 2024, 4:00 PM
1.140
+0.040 (3.64%)
After-hours: Jul 2, 2024, 7:46 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.60 million as of July 2, 2024. Its market cap has decreased by -53.61% in one year.
Market Cap
2.60M
Enterprise Value
-2.33M
1-Year Change
-53.61%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $56.87M to $2.60M, a decrease of -95.43%. That is a compound annual growth rate of -79.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 2.00M | -13.04% |
| Dec 29, 2023 | 2.30M | -72.29% |
| Dec 30, 2022 | 8.30M | -85.41% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exicure | 2.68M |
| Tenon Medical | 2.68M |
| Healthcare Triangle | 2.67M |
| Catheter Precision | 2.65M |
| Tharimmune | 2.60M |
| Cyclacel Pharmaceuticals | 2.43M |
| Aclarion | 2.39M |
| NovaBay Pharmaceuticals | 2.35M |